The cell and gene therapy field for cancer immunotherapy has seen major success over the past year with landmark approvals and regression in cancers of the blood. However, translating that success into solid tumors has been quite challenging.
Reporting on the Latest Cell & Gene Therapy Progress with a Focus on Solid Tumors
The cell and gene therapy field for cancer immunotherapy has seen major success over the past year with landmark approvals and regression in cancers of the blood. However, translating that success into solid tumors has been quite challenging.
Cell & Gene Therapy Day convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies.
Cell & Gene Therapy Day is available as an independent one day program with a luncheon and networking reception or attendees can register for the three day IO360˚ program, which includes the Cell & Gene Therapy day.
Sign up and follow your favorite conferences.